IFCC Executive Board: 2012-2014 Biographies

Priv. - Doz. Doctor Thomas BRINKMANN , Corporate Representative

 Thomas Brinkmann

Corporate Representative
Priv. - Doz. Doctor Thomas BRINKMANN

Unilabs
12 Place Cornavin
1201 Geneva
Switzerland
email: IFCC@unilabs.com

Thomas Brinkmann joined Unilabs in 2011 as corporate Chief Medical Officer, based in Geneva, Switzerland.

Dr. Brinkmann graduated from the University of Bielefeld, Germany, and holds a PhD in Biochemistry from the same university. In 1991/92 he worked at the Pasteur Institute, Paris, France, and from 1992-2003 as senior assistant at the Institute of Laboratory and Transfusion Medicine of the Heart and Diabetes Centre Nordrhein-Westfalen in Bad Oeynhausen, a university hospital of the Ruhr-University Bochum, Germany. In this position he was senior assistant of the medical laboratory. He gained experience in clinical chemistry, immunodiagnostics, haematology, immunohaematology, microbiology, serology, blood banking and molecular biology.

He qualified as Clinical Chemist and since 1999 he has been registered as European Clinical Chemist (EurClinChem). Since 2001 he is associate professor for clinical biochemistry at the Medical Faculty of the Ruhr-University of Bochum, Germany.

In 2003 Dr. Brinkmann decided to continue his career in the industrial sector and joined Beckman Coulter's European headquarter in Nyon, Switzerland as head of the EMEAI Scientific Group. In this position, he directed a team of physicians and scientists in Europe, Middle East, Africa and India for scientific marketing, commercial support and lobbying.

Dr. Brinkmann has actively collaborated with many IFCC Committees and Working Groups and he served as the Corporate Representative on the IFCC Executive Board from 2009-2011.

With his experience in research and routine diagnostics in laboratory medicine, in scientific marketing of a global diagnostic company and in a commercial diagnostic organisation he will continue to serve for the next three years as a link between IFCC and Diagnostic Industry.